In Brief
Through biophysical, biochemical, and structural studies, including cryo-EM, Marabelli et al. describe how NPAC promotes LSD2 productive interaction with the nucleosome in a rapid and flexible manner. Their findings provide a molecular mechanism for LSD2 activity in the context of H3K4me2 demethylation during Pol II transcriptional elongation.
INTRODUCTION
Nucleosomes are the tunable elements of chromatin. Multiple signaling pathways converge to build histone post-transcriptional modification patterns and in turn modulate the dynamics of the nucleosome by either directly affecting nucleosome stability or recruiting specific chromatin remodelers. Nucleosome assembly, disassembly, and modification are carried out by enzymatic subunits embedded within large macromolecular complexes (McGinty and Tan, 2015; Kim et al., 2019; Ricketts et al., 2019; Zhou et al., 2019) . The histone demethylases LSD1 and LSD2 represent particularly important examples for exploring fundamental molecular mechanisms underlying these processes. These two enzymes share a highly homologous catalytic domain and employ an identical flavin-dependent reaction mechanism to process the same substrate: mono-and dimethyl Lys4 of histone H3 (H3K4me1 and H3K4me2) Forneris et al., 2005; Karytinos et al., 2009; Lee et al., 2005; Shi et al., 2004) . Despite their similar catalytic cores, LSD1 and LSD2 feature distinct non-catalytic domains, which form distinguishable binding platforms for different partners and accessory subunits. The elongated tower domain of LSD1 is bound tightly to CoREST (co-repressor of RE1 silencing transcription factor [REST] ), which is necessary to grasp the histone tail from DNA (Kim et al., 2015; Pilotto et al., 2015) . LSD1/CoREST also forms a bifunctional complex with histone deacetylases (HDAC1 and HDAC2) to establish chromatin repression at gene promoters (Marabelli et al., 2016; Shi et al., 2004) . In contrast, LSD2 does not interact with HDACs and CoREST Ciccone et al., 2009; Fang et al., 2010 Fang et al., , 2013 Nagaoka et al., 2015; Zhang et al., 2013) . The biological partner of LSD2 is NPAC (a cytokinelike nuclear factor, also named GLYR1 or NP60), a multidomain protein comprising an N-terminal PWWP domain and a conserved C-terminal dehydrogenase domain ( Figure 1A ). The two are connected by a long stretch of roughly 170 residues comprising two protein-protein interaction motifs. An AT-hook module (residues 168-180) that binds and activates the mitogen-activated protein kinase (MAPK) p38a is followed by a linker segment (residues 214-225) that binds LSD2 with submicromolar affinity ( Figure 1A ; Fang et al., 2013; Fu et al., 2006) . This short NPAC segment was shown to stimulate the nucleosome-demethylase activity of LSD2 by binding to a (B) Our semisynthetic nucleosomes form a covalent adduct with the FAD of LSD2 (absorbance peak at 400 nm rather than at 458 nm, as for the oxidized enzyme).
(C) Elution profile (WTC-030S5 column, Wyatt) of semisynthetic NCP (10 mM) and LSD2 (20 mM) after 1 h of incubation with or without the NPAC linker (100 mM). Respectively, 2:2:1 and 1:1:1 stand for (LSD2/NPAC-linker) 2 /NCP and LSD2/NPAC-linker/NCP complexes. See also Figure S1 . (D) Elution profile of the LSD2/NPAC-linker/NCP sample used for cryo-EM (dashed lines; three 10/300 columns of Superdex 200 in series, GE Healthcare). Protein, DNA, and the flavin-H3 covalent adduct were detected by monitoring the absorbance at 280, 260, and 400 nm, respectively. hydrophobic groove between the amine oxidase and the SWIRM domains of the demethylase ( Figure 1A ; Chen et al., 2013; Fang et al., 2013) . Several studies consistently demonstrate that both LSD2 and NPAC localize within trimethylated Lys36 of histone H3 (H3K36me3)-rich chromatin regions of actively transcribed gene bodies (Fang et al., 2010; Fei et al., 2018; Vermeulen et al., 2010) . Depletion of either LSD2 or NPAC leads to similar inhibitory effects on gene transcription elongation (Fang et al., 2010; Fei et al., 2018) . This seems to indicate that the LSD2/ NPAC system processes chromatin before the passage of the RNA polymerase II (Pol II) elongating complex along DNA. Consistent with this hypothesis, the H3K4me2 signal decreases downstream of Pol II, and it is reconstituted immediately upstream (Barski et al., 2007) . However, it remains elusive how a repressive epigenetic signal such as H3K4 demethylation would be important for transcriptional elongation.
The LSD2/NPAC complex represents a canonical example of chromatin regulation by the interplay between catalytic and non-catalytic modules within a single multisubunit nucleosome-modifying complex, but numerous fundamental questions remain to be answered. What is the role of the characteristic noncatalytic domains of LSD2? Do they promote the engagement of the histone tail within the active site? How does the short linker sequence of NPAC stimulate nucleosome demethylation? What is the role of DNA and the histone octamer in substrate recognition? Above all, how do the different architectures of LSD1/ CoREST and LSD2/NPAC give rise to their opposing biological outcomes: gene repression by LSD1 versus transcriptional activation by LSD2? Here, we addressed these questions by cryoelectron microscopy (cryo-EM) analysis of the structure and conformational plasticity of the LSD2/nucleosome complex, as well as by dissection of the molecular properties of the multidomain protein NPAC. Our studies lead to the unexpected conclusion that instead of being a nucleosome-docking unit like LSD1/ CoREST, LSD2/NPAC is a multimeric enzyme complex exquisitely tailored for the efficient processing of nucleosomal histone tails.
RESULTS AND DISCUSSION
H3K4me1 and H3K4me2 Demethylation Is More Efficient with Longer H3-Tail Peptides but Not Affected by the NPAC Linker Our first experiments aimed to dissect the binding and kinetics of the human LSD2 demethylase reaction using the recombinant human enzyme expressed in Pichia pastoris and several mono-and dimethylated H3 N-terminal peptides (Table 1) . First, we confirmed the previously reported faster turnover rates for H3K4me2 over H3K4me1 substrates (Table 1; Chen et al., 2013) . Second, we showed that increasing the lengths of the H3 peptides improves LSD2 catalytic efficiency, with as much as an 8-fold lower K M for the dimethylated 40-residue over the 21-residue substrate. Third, the enzymatic activity was markedly affected by the ionic strength: at 100 mM NaCl, K M for the H3 1-21 peptide is 8-10 times higher compared to the value measured in the absence of salt. This effect was less pronounced on the longer H3 1-40 peptides, for which an increase in K M was only detectable at 200 mM NaCl (Table 1) .
These data indicated that residues 20-40 of the H3 tail feature improved catalytic activity. To investigate their actual contribution to binding, we studied a charge-removing double mutation, targeting two Lys residues in the 21-to 30-residue segment. We found that the K23M-K27M H3 1-40 peptide is as effective as a substrate as the wild type. Moreover, we tested LSD2 activity at 100 mM NaCl in the presence of 100 mM H3 or H3 21-40 peptides. No inhibition was observed, indicating that the standalone H3 16-40 and H3 21-40 segments bind, at best, too weakly to hamper substrate recognition by LSD2 (Table 1) . These findings highlight residues 1-20 as the main drivers of H3-tail binding to the demethylase, with the subsequent amino acids enhancing binding, especially under conditions of high ionic strength.
Next, we studied how H3 peptide demethylation is affected and potentially regulated by the NPAC linker (residues 214-225 of NPAC) ( Figure 1A ; Fang et al., 2013) . The outcome of these studies was consistent: the NPAC linker barely influences the steady-state kinetics of H3 peptide binding and demethylation. The only noticeable effect was that NPAC tends to mitigate the worsening (increasing) of peptide K M values at high NaCl concentrations (150-200 mM) (Table 1) .
NPAC Sustains Productive Nucleosome Recognition by LSD2
To focus on the recognition and demethylation mechanisms of the nucleosome, we reconstituted semisynthetic nucleosome core particles (NCPs) with a chemically modified recombinant H3 K4C-C110A double mutant exposing a propargylic group instead of the physiological dimethyl Lys4 side chain (Pilotto et al., 2015) . These semisynthetic NCPs function as a suicide substrate: their H3 tail assumes a catalytically competent conformation within the enzyme active pocket and thereby covalently attacks the flavin prosthetic group ( Figure 1B) . Formation of the covalent NCP/demethylase complex can be easily visualized and quantified by analytical size-exclusion chromatography ( Figure 1C ).
Incubation trials with LSD2 and the semisynthetic NCPs resulted in poor, albeit clearly detectable, LSD2/NCP complex formation, but the addition of the NPAC-linker peptide led to a marked 7-fold increase in formation of the complex (Figure 1C) . This value matches the reported NPAC effect on nucleosome demethylation by LSD2 as measured by published western blot assays Fang et al., 2013) . We systematically observed the presence of two peaks in the chromatograms. Based on their elution volumes and DNA content, gathered by the relative absorbance at 260 nm, we attributed the major peak to a 1:1:1 LSD2/ NPAC-linker/NCP complex and the minor peak to a 2:2:1 complex (i.e., one LSD2/NPAC bound to each H3 of the same NCP). Neither varying the ionic strength nor performing charge-removing mutations of H3 (K23M-K27M) affected nucleosome binding with or without the NPAC linker (Figure S1 ). Therefore, our semisynthetic NCPs proved to be effective, useful tools for studying nucleosome recognition by LSD2 and the activating role of NPAC. Figure S2 ). Given this result, we next assayed LSD2 in the presence of the isolated 147-bp 601 Widom DNA to probe its effect on catalysis. At low ionic strength (no NaCl added) activity was hardly detectable in the presence of DNA, both with and without the NPAC linker. The demethylase activity was recovered at 100 mM NaCl, though with a significant 3-fold increase of K M with respect to the experiments performed in the absence of DNA (Table 1) . These findings lead to the fundamental conclusion that a main source of the NCP-exerted inhibition is DNA. The notion that DNA forms an intrinsic obstacle to nucleosome binding and modification is well documented, and it has been generally ascribed to the pronounced charge density of DNA (McGinty and Tan, 2015; St€ utzer et al., 2016; Gatchalian et al., 2017; Morrison et al., 2018; Weaver et al., 2018) . With reference to LSD2, this phenomenon is functionally crucial, because it is at the heart of the regulatory effect exerted by NPAC. The specific electrostatic interactions between the N-terminal, highly charged, 15 amino acids of H3 and the inner catalytic pocket of the demethylase are inevitably weakened or even compromised by the contiguous crowded-with-charge nucleosomal DNA (Table 1) . Conversely, the binding of the H3 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] segment to the outer active-site region of the LSD2/NPAC-linker complex depends less on charged groups (see Table 1 and the K23M-K27M mutation in Figure S1C ). Instead, the binding of the H3 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] segment to the LSD2/NPAC-linker complex involves several hydrophobic contacts, especially with Phe217 of NPAC ( Figure 1A ; Chen et al., 2013; Fang et al., 2013) . These interactions are expected to become increasingly more relevant at higher ionic strengths, closer to the physiological conditions, enforcing the influence of NPAC on the LSD2 demethylase activity (Table 1) . This NPAC dependency is fully exhibited in the nucleosomal microenvironment, where not only the availability but also conformational flexibility of the tail is limited by the neighboring DNA Weaver et al., 2018) .
Single-Particle Cryo-EM Reveals that Multiple Conformations and Few Interactions Characterize the LSD2/NPAC/NCP Complex
To structurally describe the mechanism of nucleosome binding by LSD2/NPAC, we carried out single-particle cryo-EM. We initially employed the semisynthetic nucleosomes reconstituted with the 167-bp 601 Widom sequence that comprises the DNAlinker segments, but the resulting LSD2/NPAC-linker/nucleosome complex could not be separated from the unbound nucleosomes. The semisynthetic NCPs reconstituted with the 147-bp 601 DNA gave excellent chromatographic profiles and enabled the preparative milligram-quantity purification of the covalent LSD2/NPAC-linker/NCP complex ( Figure 1D ). The specific cross-linking between the LSD2 flavin and the modified H3K4 enabled the purification of an otherwise inherently short-lived enzyme-substrate complex, without the need for external cross-linking agents ( Figure 1B ). The cryo-EM analysis revealed five distinct structures, and three of them (classes 2-4) correspond to clearly defined LSD2/nucleosome complexes ( Figure 2 ). The demethylase region of the map is always less resolved, suggesting local variability of the LSD2 orientation, but the structures are still fully interpretable (Figures S3 and S4) .
In class 2, the body of LSD2 arches over the nucleosome dyad ( Figure 2A ). The contacts between LSD2 and NCP are confined to two small areas ( Figure 3A ). In the first one, the H3-tail-binding loop (residues 478-482) of the LSD2 amine oxidase domain contacts the two base pairs of the nucleosomal DNA entry-exit point. In the second contact region, a loop on the C4H2C2 domain of LSD2 (residues 101-107) interacts with a short segment of the H3 a1 helix (around Glu73) and the N-terminal tail of H4 (around Asp24). The trace of the H3 N-terminal segment between the LSD2 catalytic pocket and the nucleosome exit point cannot be revealed at the resolution of our density maps. However, structural analysis predicts that both H3 histones of the NCP can be engaged by LSD2. The first possibility is in line with the LSD2/NPAC-linker/H3 1-26 co-crystal structure: residues 23-35 of H3 extend over a distance of $33 Å from the rim of the LSD2 catalytic cleft to the site where the tail protrudes from the nucleosome (dashed in Figure 3A , middle). The second possibility is that Met15 of H3, at the entrance of the LSD2 catalytic pocket, is connected to Lys36, located at the nucleosomal exit point that is closer to LSD2 amine oxidase (35-Å distance) (dashed in Figure 3A , left).
In class 3, the L-shaped LSD2 arches over the edge of the NCP and protrudes laterally from the nucleosomal disk ( Figure 2A ). The single contact point between the demethylase and the NCP involves a loop on the LSD2 linker region (residues 275-280) and the nucleosomal DNA at the super-helical location (SHL) ± 2 ( Figure 3B ). The distance covered by H3 from Met15 within the LSD2 active site to Lys36 in the NCP is $43 Å , which is compatible with multiple extended conformations of the tail (dashed in Figure 3B , right).
From the inspection of the less well-defined class 4 map, it can be inferred that LSD2 sits tangentially to the NCP disk in proximity of the SHL ± 6 (Figure 2A ). The putative contact areas on the NCP comprise a few nucleotides, together with residues from H2A (a2 and a3 helices) and H2B (loop a1-a2), close to the acidic patch ( Figure 3C ).
Despite their strikingly different binding configurations, the LSD2/NPAC-linker/NCP structures share a few insightful features. In all cases, the demethylase-NCP contacts are confined to a few amino acids and nucleotides and there is no extensive interacting surface between the two components. Furthermore, the H3 segment linking the LSD2 active site to the NCP corefrom Met15 to Lys36-is always predicted to follow trajectories running along the DNA grooves. Consistently, these trajectories fall within the ensembles of nucleosomal H3-tail conformations revealed by NMR and computational studies ). These findings demonstrate that the flexibility of the H3 tail enables multiple and catalytically active binding poses with limited contacts between the LSD2 and the nucleosomal main body.
The cryo-EM analysis revealed two other classes comprising isolated NCPs, though in different states. Class 1 contains roughly half of the particle images and corresponds to the isolated and fully assembled NCP at an overall resolution of 4.02 Å ( Figures 2B, S3 , and S4). Class 5 represents a hexasome, with its visible protruding DNA. The density map for this class shows that one H2A-H2B dimer is missing and, on the side of the nucleosome where DNA slipped away, the N-terminal a helix of H3 is unfolded ( Figures 2C, S3 , and S4). The histone-DNA particle featured by class 5 was described previously as a state of nucleosome dynamics and/or unfolding (Bilokapic et al., 2018) . Therefore, the same cryo-EM grid allowed us to visualize a partly unfolded NCP, a fully folded particle, and three LSD2 complexes in different conformations.
LSD2 Engages the DNA Template via Electrostatic Interactions
Inspection of the LSD2 protein surface outlines several clusters of positively charged side chains, mostly localized on the zincfinger domain and in contact with DNA, as shown by the cryo-EM three-dimensional structures ( Figures 4A and 4B ). To investigate the specificity and magnitude of these interactions, we carried out fluorescence polarization experiments with a 21-bp oligonucleotide. At low ionic strength, full-length LSD2 exhibited nanomolar affinity for DNA, whereas at 100 mM NaCl, the condition used for cryo-EM sample preparation and binding studies, the affinity became barely detectable ( Figure 4C ; Table S1 ). To gain more insights into DNA binding by LSD2, we mutated nine Arg and Lys residues that are part of the class 2 and class 3 LSD2/NCP interactions ( Figures 4A and 4B) , as well as two highly charged disordered segments (the N-terminal 30 residues and the conserved loop 241-258 at the rim of the H3-binding cleft) ( Figure 1A ). The mutations did not affect DNA binding, with the exception of the N-terminal D30 variant, which featured a The quality of the density maps can be best appreciated at the left, whereas model fitting can be best visualized at the right. H2A, H2B, H3, and H4 are shown in dark gray, light gray, purple, and pink, respectively. LSD2 (PDB: 4hsu) is in light blue. The NCP structure used for map fitting was obtained from PDB: 6esf. The DNA molecule is entirely visible in all maps. The first and the last three base pairs were modified to match our 601 sequence exactly. See also Figures 10-fold decrease in affinity ( Figure 4C ; Table S1 ). We also found that all mutants bind NCP without drastic alteration in their efficiency with respect to wild-type protein ( Figure 4D ). These data corroborate the structural findings: LSD2 can weakly bind DNA through salt-sensitive electrostatic interactions. This association is likely brought about by various positively charged patches and does not depend on any specific cluster of residues and/or specific binding geometry.
The PWWP Domain of NPAC Is a H3 Reader and Strongly Binds DNA In addition to the short LSD2-stimulating linker sequence, NPAC comprises several domains whose molecular functions remain poorly defined ( Figure 1A) . The NPAC N-terminal PWWP module is homologous to other known H3K36me3 binders (Qin and Min, 2014) , in agreement with the NPAC localization at H3K36me3 chromatin loci (Vermeulen et al., 2010) . However, NPAC has been shown to bind nucleosomes both with and without specific epigenetic marks (Fei et al., 2018; Sankaran et al., 2016) . To determine whether the NPAC PWWP domain is a genuine histone reader, we used the SPOT-peptide array technology, employing a large library of epigenetically modified H3 and H4 peptides (Table S2) . We observed a clear selectivity toward peptides containing residues 35-40 of H3, without an evident preference for specific epigenetic markers ( Figure S5A ). Consistent with this result, isothermal calorimetry performed with the unmodified H3 1-40 peptide yielded a K d value of 30 mM ( Figure S5B ). The unfavorable reduction of conformational entropy upon binding is likely induced by the PWWP-guided partial folding of the 40-residue long peptide, in congruence with the previously characterized PWWP domain-histone peptide interactions (Eidahl et al., 2013; van Nuland et al., 2013) . Bio-layer interferometry experiments on H3 28-48 peptides confirmed the affinity for the H3 C-terminal portion of the H3 tail, with no preference for the methylation states of K36 ( Figure S5C ). Next, we explored the capability of the NPAC PWWP domain to bind DNA. Fluorescence polarization experiments revealed a strong-primarily electrostatically driven-interaction, described by K d = 0.68 mM at 100 mM NaCl ( Figure S5D ). Collectively, these observations highlight the PWWP of NPAC as a potent chromatin binder with very high DNA affinity when compared to other proteins of the same family (van Nuland et al., 2013; Weaver et al., Table S1 . (D) Qualitative evaluation of LSD2 mutations on LSD2/NPAC-linker/NCP complex yield. The histogram shows the ratio of the LSD2/NPAC-linker/NCP peak to the absorbance of the free NCP peak (both recorded at 260 nm). The ratios are reported as percentages with reference to LSD2 wild type, which was given the 100% value.
2018; Wen et al., 2014) . NPAC has been proposed to function as a nucleosome-destabilizing factor (Fei et al., 2018) . Given its tight binding properties, the PWWP is likely responsible for this activity. In the course of our experiments, the nucleosomes tended to extensively precipitate upon mixing with the protein domain, corroborating this hypothesis.
NPAC Dehydrogenase Domain Is a Catalytically Inert, Tetramerization Module
The C-terminal domain of NPAC (residues 261-553) ( Figures 1A  and 5A ) belongs to the highly conserved family of b-hydroxy acid dehydrogenases: cytosolic enzymes catalyzing the NAD + -or NADP + -dependent oxidation of specific b-hydroxy acid substrates (Njau et al., 2001; Zhang et al., 1999) . Sequence homology correlates the dehydrogenase domain of NPAC to glyoxylate reductase. Despite featuring this fascinating topology for a chromatin protein, the function of the NPAC dehydrogenase domain remains unknown. As part of our investigation of the LSD2/NPAC system, we first confirmed that the protein tightly binds nicotinamide adenine dinucleotide phosphate (NADPH; Figure S6 ).
Moreover, gel filtration and small-angle X-ray scattering (SAXS) firmly demonstrated that the protein is tetrameric in solution (Fig- ures 5B and S7; Table S3 ) (PDB: 2uyy). Therefore, the NPAC dehydrogenase domain is a tetrameric NADH-or NADPH-binding protein that displays features typical of the b-hydroxy acid dehydrogenases. We observed that the NPAC dehydrogenase domain hosts a methionine residue (Met437) in place of the highly conserved and catalytically essential lysine shared by all b-hydroxy acid dehydrogenase enzymes (Figures 5A and 5B ). This finding strongly suggests that NPAC is catalytically inert, at least as a dehydrogenase enzyme. Consistently, a methionine or an asparagine at this position is a conserved feature among all NPAC orthologs exhibiting the LSD2-binding linker sequence ( Figure 5A ). Along these lines, we characterized two mutants: M437K and M437N. Surprisingly, the M437K protein proved to be monomeric but aggregation prone ( Figure 5C ) and far less stable than the wild type (10 C lower melting temperature). Conversely, the M437N mutant retained the tetrameric arrangement and, upon addition of NADPH, exhibited a thermostability value comparable to that of the wild-type protein. Combining these results, we concluded that in the course of evolution, NPAC lost essential catalytic elements but retained NADH or NADPH binding and consolidated a stable tetrameric assembly. Therefore, the dehydrogenase domain has all features of a stable oligomerization module.
LSD2/NPAC Is a Multimeric Complex
To broaden our understanding of LSD2/NPAC, we designed a human NPAC variant that comprised both the LSD2-binding linker and the C-terminal dehydrogenase domain (NPACD205) ( Figure 1A ). This protein behaved as predicted: it was tetrameric (SAXS data in Figure S7 and Table S3 ) and retained the ability to bind LSD2 and sustain nucleosome recognition ( Figure 6A ).
These properties enabled the reconstitution of large complexes involving LSD2, tetrameric NPAC, and NCP. With increasing NCP and LSD2 relatively to the NPACD205 tetramer, a larger assembly (peak C in the chromatogram of Figure 6A ) was favored over a minor yet conspicuous complex species (peak B), which instead prevailed at higher NPACD205 concentrations. The peak C complex featured higher DNA content than the peak B species, as indicated by the DNA-to-protein absorbance ratios (A 214 /A 260 ). The large ($0.5 MDa) size of these complexes was confirmed by SAXS ( Figure S7 ; Table S3 ). The interpretation of these data is inherently challenging due to the complexity of a system comprising multivalent binding species: the tetrameric NPAC, the dimeric histone core of the nucleosome, and the monomeric LSD2. Nevertheless, the chromatographic profiles, (Table S3 ). Decreasing relative amounts of NPACD205 with respect to nucleosome and LSD2 favors the formation of species at a higher molecular weight with greater DNA content (peak C), as calculated from the A 214 /A 260 ratio, which reflects the protein/DNA content. Peak A elutes at the same volume of the LSD2/NCP complex containing the NPAC linker only (V e = 2.35 mL). This peak, occasionally present in the chromatograms, is a species that has lost an intact NPACD205 (likely by proteolysis). The experiments were performed on a WTC-030N5 column. See also Figure S7 and Table S3 . (B) Dehydrogenase domain of NPAC forms a stable tetramer decorated by flexible N-terminal arms, which comprise a PWWP domain, an AT-hook region predicted to bind DNA, and the LSD2-activating segment.
DNA content analysis, and SAXS data convincingly converge toward the idea that with increasing LSD2 and NCP concentrations, multimeric assemblies form, containing multiple copies of LSD2 and NCP per NPAC tetramer (Table S3) .
CONCLUSIONS
The key finding of our work is that LSD2 and NPAC constitute a multimeric system with a rigid core and flexible units. The N-terminal portions of NPAC stretch out from the C-terminal stable tetrameric core, evolved from an ancestral dehydrogenase enzyme. Each of these flexible arms exposes two chromatinbinding modules plus a chromatin-modifying enzyme. The AT hook and the PWWP grasp the nucleosomal particles, possibly increasing the avidity and processivity of neighboring LSD2 enzymes ( Figure 6B ). The positively charged surface patches featured by LSD2, particularly by the zinc-finger domain, enable its weak association with nucleosomal DNA. Such short-lived encounter complexes drive the formation of the catalytically productive LSD2/NPAC/nucleosome interactions that rely on the NPAC-favored capture of the H3 tail by LSD2. This mode of nucleosome recognition, together with the multimeric architecture of the complex, seems exquisitely suited for processive nucleosome modification, in association with the rapidly advancing RNA polymerase on gene bodies.
It is instructive to compare these mechanistic features with those described for LSD1, the other human flavin-dependent histone demethylase. The overall architecture of LSD1/CoREST is designed to stably clamp the nucleosomes at gene promoters through tight interactions with both the H3 tail and the DNA (Baron and Vellore, 2012; Kim et al., 2015; Pilotto et al., 2015) . This nucleosome-docking mode of operation clearly contrasts with the tail-based mechanism of the multimeric and dynamic LSD2/NPAC complex. LSD1 can thereby function to stably induce repression at gene promoters, whereas LSD2 can more dynamically operate to support active gene transcription by the RNA polymerase. Given these contrasting features, it is fascinating that both flavin-dependent systems rely on structurally and mechanistically different auxiliary factors-CoREST and NPAC-to overcome the same inhibitory histone tail-sequestering effect by nucleosomal DNA. Despite their different mechanistic strategies, multidomain architectures of the auxiliary proteins, and opposing biological outcomes, these multiprotein histone demethylase complexes are tailored to license their enzymatic activities only on their appropriate target regions of the chromatin.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Protein expression All histone proteins were expressed in BL21(DE3) pLysS E.coli cells according to established protocols (Luger et al., 1997) . LSD2 fulllength proteins were expressed in E. coli BL21(DE3). Cells were grown in LB medium supplemented with 100 mg/ml ampicillin under shaking conditions till O.D. 600nm = 0.8. Induction was performed with 0.5 mM IPTG and 0.1 mM ZnSO 4 at 17 C for 18 hours. Cells were collected by centrifugation at 5000 rpm for 10 minutes and stored at À20 C. LSD2D30-expressing P. pastoris cells were grown in flasks at 30 C under shaking conditions for 72 hours and induced with methanol for 48 hours. Cells were then collected by centrifugation at 4000 rpm for 10 minutes and stored at À20 C. The PWWP domain (residues 1-105) was expressed in E. coli BL21(DE3). Cells were grown in 2xYT medium supplemented with 100 mg/ml kanamycin and 1% (w/v) glucose at 37 C until O.D. 600 reached 1. Induction was performed with 0.1 mM IPTG for 16 h at 17 C. NPACD205 (linker + dehydrogenase) was expressed in E. coli BL21(DE3) RPplus, and cells were induced by autoinducing protocol. Cells were collected by centrifugation at 5000 rpm for 10 minutes and stored at À20 C. NPAC dehydrogenase proteins were expressed in E. coli BL21(DE3) RPplus. Cells were grown in TB medium at 37 C under shaking conditions till an O.D. 600nm of 0.8. Induction was performed with 0.5 mM IPTG at 17 C overnight. Cells were collected by centrifugation at 5000 rpm for 10 minutes and stored at À20 C.
METHOD DETAILS Plasmids cloning and mutagenesis
All cloning and mutagenesis reactions were performed combining the Phusion High-Fidelity PCR Master Mix (Thermo Scientific) with the In-Fusion HD Cloning Kit (Clontech) protocols. DNA sequences were derived from the 601 Widom sequence (Lowary and Widom, 1998) . A pMA vector containing 15 copies of the 147 bp 601 Widom sequence was purchased from GeneArt. DNAs were amplified in E. coli DH5a, purified and used for nucleosome reconstitution (Luger et al., 1997) . The pET3 vectors (Ampicillin resistance) containing the sequences of the four Xenopus laevis histone proteins, were a kind gift from Dr. Toshiya Senda (Biomedicinal Information research Center, National Institute of Industrial Science and Technology, Tokyo). H3 K4C-K23M-K27M-C110A was obtained by two consecutive mutagenesis reactions starting from the H3 K4C-C110A already available in house. The sequence coding for human LSD2D30 (residues 31-822) was cloned from the full-length human gene (purchased from GeneArt) into a pJ902Express vector (DNA 2.0) with a C-terminal eGFP-His 8 tag fused to a cleavable Prescission-protease cleavage site. The vector was linearized with PmeI and inserted in the P. pastoris KM71-H strain (Invitrogen) genome through electroporation. The sequence coding for the full-length human LSD2 was cloned in a pGEX-6P-1 vector with a GST N-terminal tag fused to a cleavable Prescission-protease cleavage site. All LSD2 mutants were obtained from full length sequence (Figure 4) . The gene for human NPAC was purchased from GeneArt and cloned in pET24a, bearing an N-terminal Flag-His 8 -SUMO tag followed by Prescission protease recognition site. NPACD205 (residues 205-553) and NPAC-PWWP (residues 1-105) were obtained from the full-length construct. The pNIC28-Bsa4 vector carrying the N-terminal His 6 tagged NPAC dehydrogenase (residues 261-553) was a kind gift from Structural Genomics Consortium (SGC) of the University of Oxford (UK).
Proteins purification
All purifications were carried out at 4 C, except for the histones, DNA sequences, and NPAC dehydrogenase performed at 20 C. Chromatographic steps were performed on Ä KTA systems (GE Healthcare).
Recombinant nucleosomes were prepared according to established protocols (Luger et al., 1997) . H3 mutants K4C-C110A and K4C-K23M-K27M-C110A were alkylated with 1-methyl-1-(prop-2-ynyl)aziridinium chloride as previously described (Pilotto et al., 2015) .
LSD2D30-expressing P. pastoris cells were re-suspended in 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 5% (v/v) glycerol, 25 mM imidazole, 2 mg/ml DNase, and 1 mM PMSF. Zirconia beads (BioSpec products) were used to lyse the cell in a bead-beater. Then beads were removed with a Miracloth filter paper (Merck) and the cell extract was centrifuged at 70,000 g for 30 min. The supernatant was loaded onto a His-Trap column (GE Healthcare). After a wash with 40 mM imidazole, the elution was obtained with 250 mM imidazole. The sample was supplemented with Prescission protease and dialyzed overnight in the same lysis buffer without imidazole. The day after a second His-Trap column step was used to purify the tag-free protein at 40 mM imidazole. The sample was then gel filtered through a Superdex 200 10/300 (GE Healthcare) equilibrated in 20 mM Tris pH 8 (25 C), 100 mM NaCl, 1 mM TCEP. LSD2 expressing E. coli BL21(DE3) cell pellets were re-suspended in 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 5% (v/v) glycerol, 25 mM imidazole, 2% (w/v) lysozyme, and 1 mM PMSF. Cell suspension was sonicated and centrifuged at 70,000 g for 30 min. The supernatant was loaded onto a GST-Trap column (GE Healthcare) and the tagged-protein eluted with 50 mM GSH. His-Prescission protease was added (1 mg/15 mL of sample). The sample was dialyzed overnight in 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl and 5% glycerol. After dialysis, the sample was loaded onto a second GST-Trap to remove the GST-tag. The unbound fractions were then loaded onto a His-Trap column to remove the His-tagged protease. A final size-exclusion chromatography step was performed on a Superdex 200 10/300 equilibrated in 20 mM Tris pH 8 (25 C), 200 mM NaCl, 1 mM TCEP. The PWWP domain (residues 1-105) expressing cells were resuspended in 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 5% (v/v) glycerol, 1 mM PMSF and sonicated. The suspension was centrifuged at 56,000 g for 1 h and the cell extract was loaded onto a His-Trap column. The resin was washed first with 50 mM NaH 2 PO 4 pH 8.0, 1 M KCl, 5% (v/v) glycerol and then with 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 5% (v/v) glycerol, 50 mM imidazole. Elution was carried out in 50 mM NaH 2 PO 4 pH 8.0, 300 mM NaCl, 5% (v/v) glycerol, 250 mM imidazole. His-tagged Prescission protease was added and the sample was dialyzed overnight in resuspension buffer. The sample was then passed a second time through a His-Trap column, and the flow-through was collected. Finally, a Superdex 75 10/300 chromatographic step was carried out in 20 mM PIPES pH 6.5, 200 mM NaCl.
NPAC dehydrogenase cell pellet was resuspended in 50 mM HEPES pH 7.5, 500 mM NaCl, 40 mM imidazole, 5% (v/v) glycerol, supplemented with 1 mM PMSF. The suspension was lysed by sonication and centrifuged at 70,000 g for 35 min. Cell extract was loaded onto a 5 mL HisTrap column, washed and eluted in 50 mM HEPES pH 7.5, 500 mM NaCl, 250 mM imidazole. The sample step was supplemented with 6xHis-TEV protease and dialyzed overnight, against 2 L of 50 mM HEPES pH 7.5, 500 mM NaCl, 5% (v/v) glycerol. A second His-Trap column was used to remove the His-tag and TEV protease. The flow-through was loaded onto a Superdex 200 16/60 (GE Healthcare) in 50 mM HEPES pH 7.5, 500 mM NaCl, 5% (v/v) glycerol.
NPACD205 (linker + dehydrogenase) cell pellet was resuspended in 50 mM HEPES pH 7.5, 5% (v/v) glycerol, 500 mM NaCl, 40 mM imidazole, 1 mM PMSF before cell disruption by sonication and successive centrifugation at 70,000 g for 40 min. The supernatant was loaded onto a HisTrap column and the protein was eluted by adding 250 mM imidazole. Incubation with His-tagged SUMO protease was carried out overnight in dialysis against 50 mM HEPES pH 7.5, 5% (v/v) glycerol, 500 mM NaCl. Both tag and protease were removed through a His-Trap column. The flow through was loaded on a Superdex 200 10/300 in 50 mM HEPES pH 7.5, 5% (v/v) glycerol, 500 mM NaCl, 0.5 mM dithiothreitol.
Enzyme activity assays Peptides were purchased from ChinaPeptides. Activity measurements were performed with peroxidase-coupled assays on a Clariostar plate reader (BMG Labtech). The reactions were carried out in 50 mM HEPES pH 8.5, 0.1 mM Amplex Red, 0.3 mM horseradish peroxidase, 0.3 mM LSD2D30, with and without 3 mM NPAC-linker at different ionic strengths (0 mM NaCl, 100 mM NaCl, 150 mM NaCl, 200 mM NaCl). H3K4me1 and H3K4me2 H3 N-terminal peptides of different lengths (1-21, 1-30, and 1-40), and H3K4me2 K23M K27M 1-40 peptide were serially diluted. Measured fluorescence signal reflects the enzymatic conversion of Amplex Red to resorufin, as described previously (Pilotto et al., 2015) . Initial velocity values were fitted to the Michaelis-Menten equation using GraphPad Prism version 6.00 for Windows, GraphPad Software, San Diego California USA, (https://www.graphpad.com/). Inhibition assays were performed at 100 mM NaCl using H3 1-40 K4me2 substrate and 100 mM putative peptide inhibitor: H2A 1-19 , H2A 117-129 , H2B 4-19 , H3 16-40 , H3 21-40 , H4 1-30 .
Fluorescence polarization
We measured the change in polarization of a TAMRA-labeled 21-bp DNA (5 0 -AGTCGCCAGGAACCAGTGTCA-3 0 ) through a Clariostar plate reader (BMG Labtech), as previously described (Pilotto et al., 2015) . Experiments were carried out in 15 mM Tris pH 8, 0.01% (v/v) Tween 20 with 0-150 mM NaCl and 5 nM DNA. Peptide binding was measured as described (Pilotto et al., 2015) .
Analytical size-exclusion chromatography 10 mM (final concentration) semisynthetic NCPs were incubated with 20 mM LSD2D30 and 100 mM NPAC-linker (1:2:10 molar ratio) for an hour on ice in 20 mM Tris pH 7.5, 100 mM NaCl. The mixture was loaded onto silica gel columns WTC-030N5 or WTC-030S5 (Wyatt Technology) equilibrated in 15 mM HEPES pH 7.3 (25 C), 200 mM NaCl. The elution profile was recorded at 260, 280, and 400 nm.
LSD2D30 was incubated with NPACD205 and semisynthetic nucleosomes for one hour in 20 mM Tris pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, 200 mM NaCl. The mixture was loaded onto silica gel columns WTC-030N5 or WTC-030S5 (Wyatt Technology) equilibrated in 15 mM HEPES pH 7.3 (25 C), 200 mM NaCl. The elution profile was recorded at 214, 260, and 280 nm. Analytical-SEC experiments of NPAC dehydrogenase were performed with Superdex 200 5/150 (Ge Healthcare) on Ä KTAmicro system (Ge Healthcare) in buffer 50 mM HEPES pH 7.5, 100 mM NaCl, 5% (v/v) glycerol. The elution profile was recorded at 214, 260, and 280 nm.
Thermal-shift assays Thermofluor (Biorad) experiments were carried out in duplicates in 20 mL wells containing 25 mM NPAC dehydrogenase and SYPRO Orange (Invitrogen) 5X in 50 mM HEPES pH 7.5, 500 mM NaCl, 5% (v/v) glycerol without or with 50 mM NADH or NADPH.
HPLC-MS analysis
To avoid contamination by HEPES and reduce salt content, NPAC dehydrogenase protein was first passed through a Hi-Trap Desalting column (GE Healthcare) at 20 C in 200 mM NaCl, 25 mM Tris pH 7.5. Following a published protocol (Lu et al., 2018) , 25 ml samples were treated with 115 ml of 40:40:20 acetonitrile:methanol:water and fresh 0.1 M formic acid, followed by addition of 10 ml of 15% (w/v) NaHCO 3 . The mixture was incubated at À20 C for 20 minutes, and then the sample was centrifuged at 16,000 g for 30 min at 4 C. The supernatant was analyzed by LC-MS. HPLC purification and MS experiments were performed at Centro Grandi Strumenti (University of Pavia, Italy).
Peptide interaction assay (SPOT blot analysis) Cellulose-bound peptide arrays were prepared using standard Fmoc solid phase peptide synthesis on a MultiPep-RSi-Spotter (INTAVIS, Kö ln, Germany) according to the SPOT synthesis method provided by the manufacturer, as previously described (Lambert et al., 2019) . Human histone peptides (UniProt accession codes: P68431 (histone H3.1), P84243 (histone H3.3) and P62805 (histone H4)) were synthesized on amino-functionalized cellulose membranes (Whatman Chromatography paper Grade 1CHR, GE Healthcare Life Sciences #3001-878) and the presence of SPOTed peptides was confirmed by ultraviolet light (UV, l = 280 nM). The assay was performed using His 6 -tagged recombinant PWWP domain. Protein bound to peptides was detected using horseradish peroxidase-conjugated anti-His antibody (dilution 1:15000, Novagene, # 71841) and the Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific, # 32106). Chemiluminescence was detected with an image reader (Fujifilm LAS-4000 ver.2.0), typically using an incremental exposure time of 2 min for a total of 80 min. Peptide locations on the arrays and their sequences are provided in Table S2 .
Isothermal Titration Calorimetry (ITC)
Experiments were carried out on an ITC200 titration microcalorimeter from MicroCal, LLC (GE Healthcare) equipped with a Washing module, with a cell volume of 0.2003 mL and a 40 ml microsyringe. Experiments were carried out at 15 C while stirring at 1000 rpm in ITC buffer (50 mM HEPES pH 7.5 (at 25 C), 150 mM NaCl). The microsyringe was loaded with a solution of H3.1 1-40 peptide sample (1605.6 mM, in ITC buffer) and was carefully inserted into the calorimetric cell which was filled with an amount of recombinant PWWP protein (0.2 ml, 52.9 mM in ITC buffer). Following baseline equilibration an additional delay of 60 s was applied. All titrations were conducted using an initial control injection of 0.3 ml followed by 38 identical injections of 1 ml with a duration of 2 s per injection and a spacing of 120 s between injections. The titration experiments were designed as to ensure complete saturation of the proteins before the final injection. The heats of dilution were independent of the peptide concentration and corresponded to the heat observed from the last injection, following saturation of ligand binding, thus facilitating the estimation of the baseline of each titration from the last injection. The collected data were corrected for peptide heats of dilution (measured in separate experiments by titrating the peptides into ITC buffer) and deconvoluted using the MicroCal Origin software to yield enthalpies of binding and binding constants as previously described (Filippakopoulos et al., 2012) . Thermodynamic parameters were calculated using the basic equation of thermodynamics. In all cases a single binding site model, supplied with the MicroCal Origin software package was employed. Dissociation constants and thermodynamic parameters are listed in Figure S5B .
Biolayer Interferometry (BLI)
Experiments were performed on an Octet RED384 system (Forté Bio) at 25 C in 25 mM HEPES, pH 7.5, 100 mM NaCl and 0.5 mM TCEP and 0.01% TWEEN-20 using the Forté Bio data acquisition software V.9.0.049. Biotinylated peptides (Alta Biosciences, Histone Set 1-H3 library, F9: H3 28-48 and G1: H3 28-48 K36me3) were first immobilized onto Super Streptavidin biosensors (SuperStreptavidin (SSA) Dip and Read Biosensors for kinetic #18-0011, Forté Bio), pre-equilibrated in the BLI buffer then quenched in a solution of 5 mM Biotin: baseline equilibration 60 s, peptide loading for 240 s, quenching for 60 s, 1000 x rpm shake speed, at 25 C. The immobilized peptides were subsequently used in association and dissociation measurements performed within a time window of 600 s (base line equilibration 120 s, association for 240 s, dissociation for 240 s, 1000 x rpm shake speed, at 25 C). PWWP concentrations (0.082, 0.24, 0.74, 2.22, 6.66, 20 , and 60 mM) were used in order to determine binding constants. Interference patterns from peptide-coated biosensors without protein were used as controls. After referencing corrections, the subtracted binding interference data were analyzed using the Forté Bio analysis software (Forté Bio data analysis software V.9.0.014) provided with the instrument following the manufacturer's protocols. SAXS SEC-SAXS experiments were performed at BM29 beamline of ESRF (Grenoble, France). All samples were analyzed using Nexera High Pressure Liquid Chromatography (HPLC; Shimadzu) system connected online to SAXS sample capillary (Brennich et al., 2017) . About 0.2-0.3 mg of sample were injected, at the flow rate of 0.25 mL/min, onto a WTC-030N5 column (Wyatt Technology) pre-equilibrated with 15 mM HEPES pH 7.3, 200 mM NaCl at 20 C. Scattering data were recorded using per sec frame rate on Pilatus 1 M detector located at a fixed distance of 2.87 m from the sample, allowing a global q range of 0.03-4.5 nm with a wavelength of 0.01 nm. Data analysis of collected frames, including blank subtraction and averaging, was carried out using Chromix (Panjkovich and Svergun, 2018) . Radii of gyration (Rg), molar mass estimates and distance distribution functions P(r) were computed using both the ATSAS package (Franke et al., 2017; Konarev et al., 2004) and Scatter (Fö rster et al., 2010) , yielding the same values within the experimental errors (Table S3) . 
